Personalis has high upside potential if its MRD test gains Medicare reimbursement, but current revenue and margins are under pressure. The company faces declining pharma revenue, sustained cash burn, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback